Wave Life Sciences Ltd. (WVE)
13.69
+0.24
(+1.78%)
USD |
NASDAQ |
Feb 09, 16:00
13.73
+0.04
(+0.29%)
After-Hours: 17:21
Wave Life Sciences Enterprise Value : 2.080B for Feb. 6, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 979.74B |
| Raffles Medical Group Ltd. | 1.407B |
| Haw Par Corp. Ltd. | 2.415B |
| Structure Therapeutics, Inc. | 3.523B |
| CytoMed Therapeutics Ltd. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -53.85M |
| Revenue (Quarterly) | 7.608M |
| Total Expenses (Quarterly) | 61.46M |
| EPS Diluted (Quarterly) | -0.321 |
| Gross Profit Margin (Quarterly) | 70.69% |
| Profit Margin (Quarterly) | -707.8% |
| Earnings Yield | -5.46% |
| Normalized Earnings Yield | -5.459 |